Massachusetts General Hospital

Massachusetts General Hospital (MGH) is one of the first academic medical centers established in the United States, known for innovations in health care and research. The Drug Allergy and Program at MGH, run by Dr. Aleena Banerji, examines patients’ drug allergies to first-line, and often life-saving, medications, ranging from antibiotics to chemotherapeutics. Patients are evaluated by trained allergy experts to ensure they can safely receive their indicated therapies with limited possibility of adverse reactions.  The MGH Drug Allergy Program evaluates and enrolls patients in two locations (Boston and Waltham, MA).

Kimberly Blumenthal, MD, MSc (Principal Investigator)

Dr. Blumenthal is an allergist/immunologist and nationally-recognized drug allergy researcher at MGH and Assistant Professor of Medicine at Harvard Medical School. She is also the Co-Director of the Division of Rheumatology, Allergy and Immunology’s Clinical Epidemiology Program and faculty in the Medical Practice Evaluation Center and MGH Mongan Institute. Dr. Blumenthal performs drug allergy research using methods of epidemiology, informatics, economics, and decision science and has more than 60 peer-reviewed publications to date.

Aleena Banerji, MD

Dr. Banerji is a nationally-recognized drug allergy and angioedema expert. She has authored over 70 peer-reviewed publications and serves as the Director of the Drug Allergy Program at Massachusetts General Hospital.